Werbung
The project will also provide open
access to state-of-the-art biolmedical
imaging techniques like the CT scan
which generated this image of a human
torso; © University Medical Centre
Mannheim, Medical Faculty Mannheim
From microscopy to computer tomography (CT) scans, imaging plays an important role in biological and biomedical research, but obtaining high-quality images often requires advanced technology and expertise, and can be costly. Euro-BioImaging, a project that launches its preparatory phase today, aims to provide scientists throughout Europe with open access to state-of-the-art imaging technologies at all levels of biological and biomedical research, from bench to bedside. The project is part of the European Commission’s European Strategy Forum on Research Infrastructures (ESFRI) roadmap.
During the 3-year preparatory phase, the project will develop a plan to construct and operate a set of complementary and strongly interlinked imaging infrastructure facilities. This plan will be based on a comprehensive assessment of researchers’ needs in terms of access, service, and training.
It aims to bring together key research areas, from basic biological imaging and molecular imaging to the clinical and epidemiological level of medical imaging. The project intends to address the current fragmentation of imaging infrastructure in Europe, by creating a coordinated and harmonised plan for its deployment throughout the continent. It will provide scientists in Europe with open access to state-of-the-art imaging technologies and training, continuously developing imaging technologies to offer cutting-edge services to the scientific community.
“Given the broad range of imaging technologies coordinated through Euro-BioImaging, the research infrastructure will facilitate the translation from basic results to medical applications,” says Stefan Schönberg from the University Medical Centre Mannheim, scientific coordinator for biomedical imaging on behalf of the European Institute for Biomedical Imaging Research (EIBIR).
COMPAMED.de; Source: European Molecular Biology Laboratory (EMBL)